Rattanabunyong, S.; Seetaha, S.; Choowongkomon, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Santanirand, P.; Chen, Z.; Zhu, W.; Blood, R.; Takebayashi, Y.; Hinchliffe, P.; Mulholland, A.; Spencer, J.; Pungpo, P. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography. J. Chem. Inf. Model. 2020, 60(1), 226-234.

27 Jan 2020
0
0

Rattanabunyong, S.; Seetaha, S.; Choowongkomon, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Santanirand, P.; Chen, Z.; Zhu, W.; Blood, R.; Takebayashi, Y.; Hinchliffe, P.; Mulholland, A.; Spencer, J.; Pungpo, P. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography. J. Chem. Inf. Model. 2020, 60(1), 226-234.

Tags

Share this

Related Posts

The selectable antibiotic marker, tetA(C), increases Pseudomonas aeruginosa susceptibility to the herbicide/superoxide generator, paraquat. Sornchuer P, Namchaiw P, Kerdwong J, Charoenlap N, Mongkolsuk S, Vattanaviboon P. Microbiology. 2014 Feb;160(Pt 2):458-66. doi: 10.1099/mic.0.072470-0. Epub 2014 Jan 2.
28 Dec 2014
0

The selectable antibiotic marker, tetA(C), increases Pseudomonas aeruginosa susceptibility to the herbicide/superoxide generator, paraquat. Sornchuer P, Namchaiw P, Kerdwong J, Charoenlap N, Mongkolsuk S, Vattanaviboon P. Microbiology. 2014 Feb;160(Pt 2):458-66. doi: 10.1099/mic.0.072470-0. Epub 2014 Jan 2.

The selectable antibiotic marker, tetA(C), increases Pseudomonas aeruginosa susceptibility to the herbicide/superoxide generator, paraquat. Sornchuer P, Namchaiw P, Kerdwong J, Charoenlap N, Mongkolsuk S, Vattanaviboon P. Microbiology. 2014 Feb;160(Pt 2):458-66. doi: 10.1099/mic.0.072470-0. Epub 2014 Jan 2.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More